申请人:BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
公开号:US11046670B2
公开(公告)日:2021-06-29
Disclosed herein, inter alia, are piperazinyl norbenzom orphan compounds and uses thereof, including, for example, methods for treating a CNS disease, treating traumatic brain injury, improving cognition, or diagnosing and treating cancer.
本文特别公开了哌嗪基诺贝能孤儿化合物及其用途,例如包括治疗中枢神经系统疾病、治疗脑外伤、改善认知或诊断和治疗癌症的方法。